Canopy Growth Establishes New US$200 Million At-The-Market Program to Strengthen the Company’s Financial Position

SMITHS FALLS, ON. August 29, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new at-the-market equity program (the “ATM Program”) that allows Canopy Growth to issue and…

Continue Reading

Canopy Growth Announces Mailing and Filing of Proxy Materials for Annual General and Special Meeting and Urges All Shareholders to Vote Now

Voting is important and easy; shareholders are urged to vote today to help the Company avoid incurring additional costs. Canopy Growth shareholders with a 16-digit control number can vote online at http://proxyvote.com, and by phone at 1-800-474-7493. For more information, shareholders should contact Canopy Growth’s strategic shareholder advisor and proxy solicitation agent, Laurel Hill Advisory Group, at 1-877-452-7184 (1‑416‑304‑0211…

Continue Reading

Canopy Growth Reports First Quarter Fiscal 2026 Financial Results; Cannabis revenue increased 24% year-over-year

Canada adult-use cannabis Q1 FY2026 net revenue increased 43% year-over-year, benefiting from increased distribution and strong consumer demand for new products, including Claybourne infused pre-roll joints Company has achieved $17MM of planned $20MM annualized savings target since March 1, 2025; SG&A expenses down 21% year-over-year in Q1 FY2026 compared to Q1 FY2025 Supply chain improvements…

Continue Reading

Canopy Growth Expands Global Medical Portfolio with Launch of 7ACRES in Australia

Launch complements existing Tweed and Spectrum Therapeutics product portfolio SMITHS FALLS, ON. August 5, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has introduced its Canadian-grown 7ACRES brand in Australia, expanding the Company’s medical cannabis…

Continue Reading

Canopy Growth Appoints Miles Worne as Managing Director of European Markets

Appointment reinforces Canopy Growth’s focus on accelerating growth in Europe and delivering on its Global Medical strategy SMITHS FALLS, ON. July 31, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the appointment of Miles Worne…

Continue Reading

Leave us a message

  • Required
  • Required
  • Required
  • Required